Beranda › Degenerasi Makula › Florida › Pensacola
Uji klinis Degenerasi Makula di Pensacola, FL
5 studi untuk Degenerasi Makula mencari peserta di lokasi sekitar Pensacola (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Menerima pesertaFase 2/3
- Retina Specialty Institute, Pensacola
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Menerima pesertaFase 2
- Retina Specialty Institute, Pensacola
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Menerima pesertaFase 1
- Retina Specialty Institute, Pensacola
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Menerima pesertaFase 1/2
- Retinal Specialty Institute, Pensacola
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Menerima pesertaFase 3
- Retina Specialty Institute, Pensacola
Uji klinis Degenerasi Makula di kota lain
- Dallas, TX13 studi
- Erie, PA10 studi
- The Woodlands, TX9 studi
- Sacramento, CA8 studi
- Hagerstown, MD8 studi
- Reno, NV8 studi
- Phoenix, AZ7 studi
- Cleveland, OH7 studi
- Houston, TX7 studi
- Salt Lake City, UT7 studi
- Boston, MA7 studi
- Austin, TX7 studi
Studi lain di Pensacola
- Gagal Jantung6 studi
- Obesitas6 studi
- Fibrilasi Atrium5 studi
- Penyakit Kardiovaskular5 studi
- Limfoma Burkitt4 studi
- Kelebihan Berat Badan4 studi
- Penyakit Crohn3 studi
- Atrofi Geografis3 studi
- Kanker Paru Non-Sel Kecil3 studi
- Kolitis Ulseratif3 studi
- Leukemia Biphenotypic Akut3 studi
- Leukemia Mieloid Akut3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.